News
Patent Application for Nucleic Acid Drugs Targeting IncRNA
Mitsubishi Gas Chemical Company, Inc. (MGC; Head Office: Chiyoda-ku, Tokyo Japan; President: Yoshinori Isahaya) and Veritas In Silico Inc. (VIS; Head Office: Shinagawa-ku, Tokyo Japan; CEO: Shingo Nakamura) are pleased to announce the filing of a patent application for a jointly developed substance related to nucleic acid pharmaceuticals.
For details, please refer to the website below.
Website: https://www.mgc.co.jp/eng/corporate/news/2026/260803e.html